RLAY logo

Relay Therapeutics, Inc. (RLAY) EV/EBITDA

EV/EBITDA:

-2.57+0.01(+0.39%)
November 26, 2025

Summary

  • As of today, RLAY EV/EBITDA is -2.57, with a rise of +0.01 (+0.39%) during the most recent trading session on November 26, 2025.
  • Over the past year, RLAY EV/EBITDA has dropped by -2.55 (-12750.00%).
  • RLAY EV/EBITDA is now -398.84% below its all-time high of 0.86.

Performance

RLAY EV/EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

OtherRLAYvaluation metrics

EV/EBITDA Formula

EV/EBITDA =  
Enterprise Value
TTM EBITDA

RLAY EV/EBITDA Trends

PeriodPeriodEV/EBITDAEV/EBITDAEnterprise ValueEnterprise ValuePricePrice
1D1 Day+0.4%-0.4%-0.3%
1M1 Month-33.9%+33.4%+17.1%
3M3 Months-6525.0%+6861.6%+126.8%
6M6 Months-684.1%+604.4%+175.9%
YTDYTD-2436.4%+2088.8%+94.9%
1Y1 Year-10000.0%+10000.0%+68.7%
5Y5 Years+93.0%-80.1%-85.1%

RLAY EV/EBITDA Highs & Lows

PeriodPeriodHighHighCurrent vs Highvs HighLowLowCurrent vs Lowvs Low
1M1-Month-1.50-71.3%-2.64+2.6%
3M3-Month0.04-6525.0%-2.64+2.6%
6M6-Month0.47-646.8%-2.64+2.6%
1Y1-Year0.86-398.8%-2.64+2.6%
3Y3-Year0.86-398.8%-5.92+56.6%
5Y5-Year0.86-398.8%-93.37+97.3%
All-TimeAll-Time0.86-398.8%-93.37+97.3%

RLAY EV/EBITDA History

DateValue
2025
-2.57(-2436.4%)
2024
0.11(+105.8%)
2023
-1.89(+33.2%)
DateValue
2022
-2.83(+73.6%)
2021
-10.70(+81.9%)
2020
-59.01

FAQ

  • What is Relay Therapeutics, Inc. EV/EBITDA?
  • What is the all-time high EV/EBITDA for Relay Therapeutics, Inc.?
  • What is RLAY EV/EBITDA year-to-date change?
  • What is Relay Therapeutics, Inc. EV/EBITDA year-on-year change?

What is Relay Therapeutics, Inc. EV/EBITDA?

The current EV/EBITDA of RLAY is -2.57

What is the all-time high EV/EBITDA for Relay Therapeutics, Inc.?

Relay Therapeutics, Inc. all-time high EV/EBITDA is 0.86

What is RLAY EV/EBITDA year-to-date change?

Relay Therapeutics, Inc. EV/EBITDA has changed by -2.68 (-2436.36%) since the beginning of the year

What is Relay Therapeutics, Inc. EV/EBITDA year-on-year change?

Over the past year, RLAY EV/EBITDA has changed by -2.55 (-12750.00%)
On this page